Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD6 is a human cell surface glycoprotein primarily expressed on T lymphocytes, playing a crucial role in T cell activation, proliferation, and adhesion. It interacts with ligands like CD166/ALCAM and CD318/CDCP1, influencing immune synapse stability and signal transduction. Variants in the CD6 gene are associated with autoimmune diseases, and its interaction with ALCAM in cancer is being explored for immunotherapy.
Modulation of T cell activation and adhesion through interaction with ligands like CD166/ALCAM and CD318/CDCP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cluster of Differentiation 6 (CD6).